Li Lab

From OpenWetWare
Jump to navigationJump to search

Baylor Blackboard.jpg Home        People        Publications        Collaborations        Software        Positions        Contact       

Recent News

. 05/2019: Collaborative work with Paolo Sassone-Corsi at UCI was published in Cell

. 02/2019: Our new 5-year NCI R01 grant regarding DNA methylation canyon was funded.

. 07/2018: Jianzhong's DNA methylation canyon paper was accepted to Genome Biology.

. 06/2018: Jiejun’s paper was accepted to Nature Cell Biology.

. 06/2018: Xueqiu's DNMT3A binding paper was accepted to Genome Biology

. 03/2018: HJ Park's papers were accepted to PLOS Computational Biology and Cell Reports, respectively.

. 01/2018: HJ Park's 3'UTR vs ceRNA paper was finally accepted to Nature Genetics after 1.5 years and 3 rounds of revisions/appeals. A good start of the new year!

. 12/2017: Jiejun and Jie's collaborative papers with Xiaobing Shi were accepted to Genes & Development and Nature Communications, respectively

. 09/2017: Feng Xin and Lei Li's paper on TC3A: The Cancer 3’ UTR Atlas was accepted to Nucleic Acids Research.

. 09/2017: Hyun Jung Park has been offered a tenure-track Assistant Professor position at University of Pittsburgh Medical Center. Congratulations.

. 08/2017: Xueqiu's scUMC DNA methylation paper was accepted to Genome Biology.

. 07/2017: Jianzhong's DNA methylation editing papers with the Goodell lab were published in Nature Communications and Genome Biology.

. 05/2017: Our TCGA Liver Cancer paper was accepted to Cell.

. 02/2017: Our Research Center for Cancer Systems Biology (CCSB U54) grant was funded by NCI, in collaboration with Qianben Wang, Victor Jin and Tim Huang.

. 02/2017: Collaborative work with Xiaobing Shi and David Allis was accepted to Nature.


News Archive

Our lab is focused on the design and application of bioinformatics algorithms to elucidate global epigenetic mechanisms in normal development and diseases such as cancer. Our areas of expertise include 1) DNA methylation using Bisulfite-seq; 2) Epigenetic regulation using ChIP-seq; 3) Alternative Polyadenylation (APA); 4) Non-coding RNA; 5) Nucleosome organization using MNase-seq. Since establishing our own bioinformatics lab in early 2008, we have (as of December 2018)

  • Published 131 peer-reviewed papers through solid methodology development and extensive collaboration research, including 20 senior-author papers in Nature and Cell series.
  • Been well-funded with total external funding >$1.0 million per year, including 4 PI grants from NIH and Texas CPRIT: NIH R01HG007538 (2013-2019), R01CA193466 (2015-2020), R01 CA228140 (2019-2024) and U54CA217297 (2017-2022).
  • Mentored the first 7 postdoc trainees to start their tenure track faculty positions in prestigious research institutions in the US (6) and China (1).

1) DNA methylation using Bisulfite-seq. Our lab developed some of the earliest and most widely used bioinformatics software to analyze whole genome bisulfite sequencing (WGBS) data, including the first WGBS mapping program BSMAP (>500 citations) and MOABS for model-based differential methylation analysis. Furthermore, we are among the first to report the sparse conserved single under-methylated CpG (scUMC) and DNA Methylation Canyon as two novel epigenetic features in the genome. Recently, our pan-cancer analysis of WGBS data followed by dCas9-mediated methylation editing, reveals gene-body canyon hyper-methylation as a novel epigenetic mechanism for oncogene activation. In collaboration with Goodell lab at Baylor, we are among the first to study de novo DNA methyltransferase 3A (Dnmt3a) using WGBS in normal and malignant hematopoietic stem cells (HSCs).

2) Epigenetic Regulation using ChIP-seq. Our lab developed some of the most widely cited bioinformatics methods to analyze ChIP-seq data, including MACS for Model-based Analysis of ChIP-seq (>5,800 citations) and MACE for Model based Analysis of ChIP-exo with single nucleotide resolution. Using MACS, we recently discovered Broad H3K4me3 (wider than 4 kb) as a novel epigenetic signature for tumor suppressor genes, such as TP53 and PTEN. In collaboration with several experimental biologists, we used ChIP-seq to gain novel biological insights into the genome-wide functions of several important epigenetic enzymes, including AR, Atoh1, FoxA1, NSD2, SIRT7, ZMYND11, YEATS, MeCP2, ZMYND8, SIRT6 and ENL.

3) Alternative Polyadenylation (APA). We developed the first bioinformatics algorithm DaPars for Dynamic Analyses of Alternative Polyadenylation directly from the widely-used RNA-Seq. In collaboration with Eric Wagner, we used DaPars to identify CFIm25, a master APA regulator, as a glioblastoma (GBM) tumor suppressor. Furthermore, our recent re-analysis of TCGA breast cancer data suggests that the major role of 3ʹ-UTR shortening in tumorigenesis is to repress tumor suppressor genes in trans by disrupting competing-endogenous RNA (ceRNA) crosstalk.

Lab Intranet openwetware